ESPRIT: European/Australasian Stroke Prevention in Reversible Ischaemia Trial
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The objective of ESPRIT was to compare the efficacy and safety of mild anticoagulation or a
combination treatment of aspirin and dipyridamole with the efficacy and safety of treatment
with aspirin alone after cerebral ischemia of arterial origin.